ArticleBMJ open2025
Trends in depression and anxiety prevalence by cancer status among US adults: analyses of the 2019-2022 National Health Interview Survey.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Factors associated with serious psychological distress among US adult cancer survivors: a cross-sectional observational analysis of the 2024 National Health Interview Survey.Journal of cancer survivorship : research and practice · 2026Article
- Suicide risk among individuals diagnosed with cancer during versus before the COVID-19 pandemic: a nationwide population-based study.Japanese journal of clinical oncology · 2025Article
- Impact of Pediatric Leukemia on Maternal Anxiety, Depression, Sleep Quality, and Physical Activity.Medical science monitor : international medical journal of experimental and clinical research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo examine trends in the prevalence of depression and anxiety during the COVID-19 pandemic among US adult cancer patients and survivors (CPS) in comparison to those of non-CPS (NCPS). METHODS AND ANALYSIS: National Health Interview Survey 2019-2022 data were analysed using spline logistic regression.
resultsA total of 115 664 participants completed the survey (mean age (SD), 52.8 (18.4) years; 54.3% female; 12.6% CPS). The age-adjusted prevalence of depression significantly increased from 26.53% in 2019 to 29.78% in 2022 among CPS, while that of anxiety increased from 24.02% in 2019 to 28.08% in 2022. Throughout the pandemic, there were consistently significant annual increases in the prevalence of both depression and anxiety with CPS experiencing significantly faster rates of increase compared with NCPS (average annual absolute increase 0.72% in NCPS vs 1.08% in CPS, p<0.01 for depression; 0.98% in NCPS vs 1.35% in CPS, p<0.01 for anxiety). Difficulty in social activity engagement emerged as the primary risk factor for both depression (adjusted OR (aOR), 7.38 (95% CI, 7.04 to 7.73), p<0.01) and anxiety disorders (aOR, 7.58 (95% CI, 7.23 to 7.95), p<0.01). Significant interactions were found between difficulty in social engagement and cancer status on the diagnoses of depression (aOR, 0.72 (95% CI, 0.63 to 0.83), p<0.01) and anxiety (aOR, 0.62 (95% CI, 0.55 to 0.70), p<0.01).
conclusionsThe notably higher prevalence and more rapid increase in rates of depression and anxiety disorders among CPS compared with NCPS underscore the disproportionate impact of the COVID-19 pandemic on CPS and the necessity of prioritising mental health support and interventions for this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.